GLP-1 Drugs Strain Employer Health Budgets | Augusta Georgia News

GLP-1 drugs are revolutionizing weight loss and diabetes care — but for employers, the cost is skyrocketing. With healthcare expenses projected to jump 9.2% by 2027, 14% of companies are cutting coverage for these meds, even as two-thirds report rising employee usage. Coverage has dropped from 72% in 2025 to 60% in 2026, forcing businesses to rethink budgets and seek smarter, more innovative ways to support health — without breaking the bank. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/165b5925b4c8e523